Results 1 to 10 of about 48,475 (244)

Pamidronate “zebra lines”: A treatment timeline [PDF]

Radiology Case Reports, 2017
Osteogenesis imperfecta is a hereditary bone dysplasia characterized by bone fragility, deformity, and short stature. Treatment focuses on preventing bone fractures and symptom relief.
Christine P Burren, MBBS, MD, FRACP, FRCPCH, Avgi Loizidou, BSc, MBChB, Savvas Andronikou, MBBCh, FCRad, FRCR, PhD   +2 more
core   +4 more sources

Pamidronate Disodium for Palliative Therapy of Feline Bone-Invasive Tumors [PDF]

Veterinary Medicine International, 2014
This study sought to quantify in vitro antiproliferative effects of pamidronate in feline cancer cells and assess feasibility of use of pamidronate in cats by assessing short-term toxicity and dosing schedule in cats with bone-invasive cancer.
David A. Heller, Jackie M. Wypij
core   +2 more sources

Pamidronate therapy as prevention of bone loss following renal transplantation1

Kidney International, 2000
Pamidronate therapy as prevention of bone loss following renal transplantation.BackgroundVery rapid bone loss, osteopenia and skeletal morbidity after renal transplantation have been well documented and found to occur in a sex dependent fashion ...
Stanley Fan
exaly   +2 more sources

Effectiveness of Pamidronate Infusion in the Treatment of Charcot Arthropathy [PDF]

Malaysian Orthopaedic Journal
Introduction: The objective of this case series is to investigate the efficacy and safety of intravenous infusion of Pamidronate, a second generation bisphosphonate, in the treatment of active Charcot arthropathy.
Adib-Adham NS, Bajuri MY, Md-Noorpi NH, Azman I, Yin MK   +4 more
core   +2 more sources

Podocyte injury associated glomerulopathies induced by pamidronate

Kidney International, 2004
Podocyte injury associated glomerulopathies induced by pamidronate.BackgroundPamidronate has been demonstrated to decrease bone-related complications in multiple myeloma and delay progression of the disease.
Yousri M Barri, Stephen M Bonsib, Patrick D Walker   +2 more
exaly   +2 more sources

Pamidronate

, 2006
europepmc   +2 more sources

A comparison of the responses to the intact pamidronate integrated model with those to the blocked pamidronate integrated model after multi-dose pamidronate administration.

, 2012
(a) The active osteoclast after multi-dose pamidronate administration. (b) The bone volume after multi-dose pamidronate administration. (c) The MM-cell density after multi-dose pamidronate administration. Blue: the intact model; Black: the blocked model.
Yan Wang (15435), Bo Lin (116835)
core   +1 more source

Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer

, 2008
Udgivelsesdato: 2008PURPOSE AND PATIENTS: During the period from January 1990 to January 1996 a total of 953 patients with lymph node negative primary breast cancer were randomised to oral pamidronate (n=460) 150 mg twice daily for 4 years or no adjuvant
Edlund, Per, Mouridsen, Henning T, Ewertz, Marianne; id_orcid, Bergh, Jonas, Andersen, Jørn, Cold, Søren, Lindman, Henrik,, Kristensen, Bent, Mouridsen, Henning T., Nordenskjöld, Bo, Ewertz, Marianne, Bjerregaard, Brita, Jensen, Maj-Britt, Nordenskjöld, Bo,, Ejlertsen, Bent, Kamby, Claus, Lindman, Henrik   +16 more
core   +2 more sources

Nephrotic syndrome induced by pamidronate

, 2010
Contains fulltext : 97151.pdf (Publisher’s version ) (Open Access)Two patients developed nephrotic syndrome and progressive loss of renal function following treatment with i.v. pamidronate.
Wetzels, J.F.M., M. A. G. J. ten Dam, J. F. M. Wetzels, Dam, M.A. ten, L. B. Hilbrands, Hilbrands, L.B.   +5 more
core   +1 more source

Treatment of experimental renal osteodystrophy with pamidronate

, 2008
We evaluated the effects of the bisphosphonate pamidronate on bone histomorphometry, structure and strength in male rats with uninephrectomy or with chronic renal disease induced by 5/6 nephrectomy.
Jokihaara, Jarkko, Mustonen, Jukka T., Turner, Russell T., Pörsti, Ilkka H., Jolma, Pasi M., Kannus, Pekka, Järvinen, Teppo L.N., Saha, Heikki H.T., Sievänen, Harri, Iwaniec, Urszula T., Kööbi, Peeter   +10 more
core   +1 more source